Ke-Ke Zhang

No ORCID on file · 3 papers in corpus · active 2024-2025

Study types

  • article 2
  • review 1

Condition tags

  • endometriosis 1
  • adenomyosis 1
article 2025
Clinical efficacy and safety of Chinese patent medicines combined with hormonal therapy for endometriosis after laparoscopic surgery: A Bayesian network meta-analysis
Complementary therapies in clinical practice ·doi:10.1016/j.ctcp.2025.102020

BACKGROUND AND PURPOSE: Chinese patent medicines (CPMs), standardized herbal formulations widely used in clinical practice, combined with hormones have shown favorable therapeutic effects in the adjuvant treatment of endometriosis (EMS) aft…

review 2025
Mitochondrial homeostasis: A key regulator in endometrial physiology and pathology
·doi:10.1016/j.drudis.2025.104519

Endometrial cyclic remodeling and decidualization are critical physiological processes for female reproductive function and are profoundly influenced by mitochondrial homeostasis. Mitochondrial homeostasis is maintained through the mitochon…

article 2024
Paris polyphylla ethanol extract and polyphyllin I ameliorate adenomyosis by inhibiting epithelial–mesenchymal transition
Phytomedicine : international journal of phytotherapy and phytopharmacology ·doi:10.1016/j.phymed.2024.155461

BACKGROUND: The active ingredients of the Chinese medical herb Paris polyphylla, P. polyphylla ethanol extract (PPE) and polyphyllin I (PPI), potentially inhibit epithelial-mesenchymal transition (EMT) in tumors. However, the roles of these…